Fibrogen CEO Conterno bought 27,800 shares at $35.47. After last year’s unexpected passing of founder and long-time helmsman Thomas Neff, FibroGen needed a permanent successor—and with its big…
We use cookies to ensure that we give you the best experience on our website. By accessing this site, you agree to be bound by the terms of service, copyright disclaimer and privacy notice.